MultiVir Inc
2 Houston Center, 909 Fannin Street
Suite 200
Houston
Texas
TX 77010-1028
United States
Tel: 832-431-3555
Website: http://www.multivir.com
Email: info@multivir.com
About MultiVir Inc
MultiVir is a clinical stage immune oncology company pioneering a new field of cancer therapeutics termed tumor suppressor immune gene therapy employing multiple viral delivery platforms.YEAR FOUNDED:
2009
LEADERSHIP:
CEO: Robert E. Sobol
COO and CFO: Nicholas Puro
CSO: Sunil Chada
2 articles about MultiVir Inc
-
MultiVir Reports Reversal of Immunotherapy Resistance by Tumor Suppressor Immune Gene Therapy
1/25/2018
MultiVir Inc presented updated data at the annual ASCO-SITC Clinical Immuno-Oncology Symposium demonstrating the ability of its immune gene therapies to reverse resistance to immune checkpoint inhibitor therapy.
-
MultiVir Reports Gene Therapy Enhancement Of Cancer Immunotherapy
5/19/2017